Lam, T. et al. 2007. Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth. Acta Oncologica. 46, 8 (Jan. 2007), 1169–1177. DOI:https://doi.org/10.1080/02841860701373603.